focus -WSS

focus

author：hotspot 2025-09-02 22:07:29 - browse：63765

Joaquin Duato -- health policy coverage from STAT — Johnson & Johnson CEO Joaquin Duato MICHAEL BUHOLZER/AFP via Getty Images

WASHINGTON — Merck CEO Robert Davis and Johnson & Johnson CEO Joaquin Duato have agreed to voluntarily testify before the Senate health committee, avoiding a threatened subpoena, the committee announced Friday.

The decision by the executives came after a public pressure campaign by Sanders to get the two executives and Bristol Myers Squibb CEO Chris Boerner to testify about why prices for their drugs are higher in the United States than in other countries. Sanders had scheduled a vote to subpoena the Merck and Johnson & Johnson CEOs on Jan. 31, but canceled it on Friday.

“The use of a subpoena was clearly a last resort and I’m delighted that these CEOs will be coming into our committee voluntarily,” Sanders said in a written statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Choosing scientific sides in the fight against Alzheimer's

knowledge

entertainment

WSS

Insmed lung disease drug hits target in key Phase 3 trial

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Astronauts get first look at the spacecraft that will fly them around the moon

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Focused ultrasound for uterine fibroids: an uphill battle

Do more moles mean more problems? Not so, says new study

hotspot

focus

explore

As demand for Covid shots wanes, Moderna seeks its next success

Health insurers say they are turning to AI to cut costs, improve care

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Antibiotic resistance nearly killed me, so I'm raising awareness of it

In Memoriam: Notable people who died in 2023

Latest bird flu infection made farmworker sicker than earlier cases

After affirmative action ruling, medical educators look to 'holistic review'

In venture capital firm's success, lessons for turning crisis into profit

Walensky prepares to leave CDC — and Congress — behind

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

knowledge

AI used to predict Covid

Focused ultrasound for uterine fibroids: an uphill battle

Discs beat pads, tampons for heavy menstrual flow, new study shows

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Health insurers say they are turning to AI to cut costs, improve care

More regulation could be coming for drug ads

knowledge

entertainment

knowledge

knowledge